IVADINE 7.5

Description

IVADRIVE 7.5 contains Ivabradine 7.5 mg, a proven heart rate–lowering medication used in the management of chronic heart failure and stable angina. Ivabradine works by selectively inhibiting the “If” current in the sinoatrial (SA) node—the natural pacemaker of the heart—leading to a controlled reduction in resting and exercise heart rate. This controlled rate reduction helps the heart function more effectively without affecting blood pressure or the strength of heart contractions. IVADRIVE 7.5 is formulated to provide improved symptom control for patients who require a higher strength dose for optimal heart rate management. Uses 1. Chronic Heart Failure (CHF) IVADRIVE 7.5 is used in patients with reduced ejection fraction to help improve cardiac efficiency. By reducing the heart rate, it eases the heart’s workload and supports better long-term heart function. 2. Stable Angina (Chest Pain) It is recommended for individuals experiencing frequent or effort-related chest discomfort. A lower heart rate reduces the oxygen demand of the heart, thereby decreasing angina episodes. 3. Heart Rate Management This higher-strength dose is often prescribed for patients who do not achieve the desired heart rate control with the 5 mg strength or those who need a stronger therapeutic response. 4. Improved Exercise Tolerance By regulating heart rate and improving cardiac efficiency, patients experience fewer symptoms such as fatigue and breathlessness during physical activities. Benefits 1. Selective Heart Rate Reduction Ivabradine 7.5 mg precisely targets the SA node without impacting blood pressure or myocardial contractility, making it well suited for patients with normal or borderline low blood pressure. 2. Reduced Angina Frequency A slower heart rate reduces the heart’s oxygen requirement, helping minimize chest pain episodes and improving comfort during exertion. 3. Enhanced Quality of Life in Heart Failure Patients with chronic heart failure benefit from improved cardiac output, reduced hospital visits, and better day-to-day wellbeing. 4. Effective Option When Beta-Blockers Cannot Be Used IVADRIVE 7.5 is useful for individuals who cannot tolerate beta-blockers or need additional therapy to achieve optimal heart rate control. 5. Proven Clinical Safety and Efficacy Ivabradine has been widely studied and is recognized globally for its role in chronic heart failure and angina management. Dosage The typical dose for adults is one IVADRIVE 7.5 tablet twice daily, preferably taken with meals. The dosage may be adjusted depending on the patient’s resting heart rate and clinical response. Do not skip or double doses. Regular monitoring of heart rate is essential to ensure safe and effective treatment. Always follow your cardiologist’s instructions and avoid self-adjusting the dose. Side Effects Most individuals tolerate IVADRIVE 7.5 well. However, some may experience: Visual brightness (phosphenes) Slow heart rate (bradycardia) Headache Dizziness Fatigue Irregular heartbeat (rare) Worsening heart failure symptoms (very rare) Seek immediate medical guidance if you notice severe dizziness, extremely low heart rate, or persistent visual disturbances. Conclusion IVADRIVE 7.5 (Ivabradine 7.5 mg) is a reliable and effective heart rate–lowering medicine designed to support long-term management of chronic heart failure and stable angina. With its selective mechanism of action, excellent tolerability, and proven benefits in improving exercise tolerance and reducing cardiac symptoms, it serves as an essential treatment option for patients needing precise heart rate control. When used under proper medical supervision, IVADRIVE 7.5 helps improve overall heart health and enhances day-to-day comfort and wellbeing.